REGENXBIO INC.
6.350 $ -5.93%
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.350 USD | -5.93% |
|
+12.39% | -55.90% |
|
REGENXBIO Inc. Presents at RBC Capital Markets Global Healthcare Conference 2026, May-20-2026 09:30 AM
May. 22 |
|
Sarepta's Elevidys Faces 'Little' Pressure After Regenxbio Data, Wedbush Says
May. 15
MT
|
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 328M | - | ||||
| 50.57B | |||||
| 46.31B | |||||
| 23.3B | - | ||||
| 23.03B | - | ||||
| 17.28B |
- Stock Market
- Equities
- RGNX Stock
- Charts REGENXBIO Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
